tiprankstipranks
Kronos Bio reports Q3 EPS (23c), consensus (28c)
PremiumThe FlyKronos Bio reports Q3 EPS (23c), consensus (28c)
9d ago
Kronos Bio files $250M mixed securities shelf
Premium
The Fly
Kronos Bio files $250M mixed securities shelf
15d ago
Kronos Bio to present data at ASH annual meeting on p300 KAT inhibitor program
Premium
The Fly
Kronos Bio to present data at ASH annual meeting on p300 KAT inhibitor program
17d ago
Kronos Bio to present preclinical data from p300 KAT inhibitor program
PremiumThe FlyKronos Bio to present preclinical data from p300 KAT inhibitor program
2M ago
Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium
Premium
The Fly
Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium
2M ago
Kronos Bio reports Q2 EPS (27c), consensus (34c)
Premium
The Fly
Kronos Bio reports Q2 EPS (27c), consensus (34c)
4M ago
Kronos Bio’s Restructuring Risks: Cost Cuts Versus Operational Efficiency
PremiumCompany AnnouncementsKronos Bio’s Restructuring Risks: Cost Cuts Versus Operational Efficiency
8M ago
Kronos Bio reports Q4 EPS (43c), consensus (52c)
Premium
The Fly
Kronos Bio reports Q4 EPS (43c), consensus (52c)
8M ago
KRON Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KRON Earnings this Week: How Will it Perform?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100